4743 (4743) News
Follow 4743 (4743) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Oneness Biotech Co., Ltd. Advances SNS851 to Phase 1 MAD
Oneness Biotech advanced its siRNA candidate SNS851 to the multiple-ascending dose part of a Phase 1 trial after completing SAD in healthy volunteers; MAD will enroll participants with fatty liver disease, with data expe
NEWS | Sep 29, 2026, 12:01 PM UTC
L
Oneness Biotech Advances SNS851 to Phase 1 Multiple-Ascending Dose Evaluation for Obesity-Associated Metabolic Diseases
Oneness Biotech Co., Ltd., a Taiwan-based biotechnology company advancing innovative drugs for metabolic disorders, today announced completion of the single-ascending dose (SAD) portion (Part A) in healthy volunteers of
GEOPOLITICS | Sep 29, 2026, 12:01 PM UTC